Denying a claim is no one’s idea of a good time, and discovering adverse selection after the contestability period is both unpleasant and costly. That’s why life and final-expense insurance carriers find that ReCheck pays for itself many times over.
ReCheck reorders a policyholder’s Prescription Data and Medical Data three to six months into the contestability period. The Irix rules engine flags potential misrepresentation and clearly identifies new drugs or treatments that indicate unreported high-risk conditions. You can use this data to precisely target investigations, allowing you to make live policy rescissions before you’re forced to deny a death claim.
ReCheck finds significant new prescription fills or undisclosed medical conditions in up to 25% of cases, then helps you to make the best use of your resources by identifying the 5% to 10% that warrant an investigation.
Hindsight really is 20/20 when you make smart use of data.
Carriers who use this powerful tool against adverse selection report better public relations and fewer legal issues, more time for thorough investigations, kinder customer service, and the ability to take action on policies that may not claim within the contestable period.
A retrospective study will prove that Irix – ReCheck delivers terrific ROI and fewer denied claims.Schedule a demo to see more
These Cookies are necessary for you to access and navigate our sites.
These Cookies are used by us or third-party service providers to analyze how the Sites are used and how they are performing. We use the following service providers and you can learn more about their privacy policies and how to opt-out of their cookies by clicking on these links: